IL1B: Interleukin-1 beta
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Potent pro-inflammatory cytokine.
- Drugs that act on it: 5
- With a US drug page: 2
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Canakinumab | Approved | Interleukin-1 beta inhibitor | Inhibitor | — |
| Rilonacept | Approved | Interleukin-1 beta inhibitor | Inhibitor | — |
| CDP-484 | — | Interleukin-1 beta inhibitor | Inhibitor | — |
| Gevokizumab | — | Interleukin-1 beta negative allosteric modulator | Negative allosteric modulator | — |
| Lutikizumab | — | Interleukin-1 beta inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Cryopyrin-associated periodic syndrome
- 0.59
- Muckle-Wells syndrome
- 0.53
- Gout
- 0.53
- Familial Mediterranean fever
- 0.51
- Familial cold autoinflammatory syndrome
- 0.47
- Immune system disorder
- 0.47
- Antisynthetase syndrome
- 0.46
- Pericarditis
- 0.46
- Atopic eczema
- 0.46
Drugs and mechanisms are from ChEMBL CHEMBL1909490 (CC BY-SA 3.0). Gene name, function (UniProt P01584, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets